K Pharma,Inc.

4896

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-12FY2026 Q2

Revenue

YoY -

Operating Income

-4.7100M JPY

YoY -7.7%

Net Income

-10.4100M JPY

YoY -20.4%

EPS

-42.4JPY

YoY -10.6%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

10億円

5億円

3.4百万円

-4.9億円

-9.9億円

Rev: 10億円Op: 3.7億円NI: 2.6億円

Rev: -Op: -8.4億円NI: -8.5億円

Rev: -Op: -9.2億円NI: -9.9億円

2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income-

Revenue Progress-

Revenue Forecast-

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan